锦欣生殖医疗集团有限公司（香港联交所上市，股票代码：01951）于2026年5月8日发布公告，披露当日于香港联交所场内回购普通股3,278,500股，占事件前已发行股本约0.12%，每股回购价格介乎港币2.39元至2.42元，合计支付7,886,759.60港元（约合788.68万港元）。此部分回购股份尚未注销。
公司表示，回购授权由股东于2025年6月26日通过，授权可回购股份总数为274,470,604股。截至公告日，锦欣生殖医疗集团在联交所及其他证券交易所已合计回购62,606,500股，占回购授权通过当日公司已发行股本约2.281%。此次回购完成后，公司已发行股本仍为2,705,044,043股，无库藏股。
公司确认，本次股份回购已遵守香港联交所证券上市规则及相关法例。该公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.